Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

What Do Billionaires Kovner and Bacon See In Morgan Stanley (MS)?

Page 1 of 2

We maintain a database of quarterly 13F filings from hedge funds and other notable investors for a variety of purposes. One of our activities is the development of workable investing strategies, and we’ve actually discovered that the most popular small cap stocks among hedge funds generate an average excess return of 18 percentage points per year (learn more about our small cap strategy). We also like to evaluate large changes in hedge fund positions, and when going through the most recent filings we noticed that billionaire Louis Bacon’s Moore Global initiated a position of 4.5 million shares in Morgan Stanley (NYSE:MS) during Q1, making the bank one of its top ten picks overall (see Bacon’s stock picks). Morgan Stanley was also Caxton Associates’s second largest holding by market value following a large increase in the fund’s position; Caxton was founded by billionaire Bruce Kovner (find Caxton’s favorite stocks).


Morgan Stanley (NYSE:MS)’s stock price is up 89% in the last year, including 34% year to date and over 20% quarter to date. Decent earnings numbers from Q1 and the fourth quarter of 2012 (with numbers for that period coming in well above expectations) fueled these gains. Still, there is some value case remaining for Morgan Stanley (NYSE:MS); for one, it trades at a discount to the book value of its equity with a P/B ratio of 0.8.

The bank’s 10-Q for the first quarter of 2013 showed decent growth rates in revenue, notably from trading activities and from net interest tilting positive; overall, revenue was up 18% versus a year earlier. Non interest expenses were actually down in absolute terms, with a 5% drop in compensation and benefits in particular. As a result Morgan Stanley (NYSE:MS) earned 48 cents per share. The trailing P/E is high because of poor results in previous periods, but if we annualize these most recent results we get an earnings multiple of 13- meaning the company needs little improvement going forward in order to be considered a value play. Wall Street analysts expect $2.55 in EPS for 2014, placing the current price at only 10 times forward earnings estimates.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!